ANTI-AGING & HEALTH RISKS MANAGEMENT
Alexander Fedintsev
Anti-ageing researcher, author of the biological age estimation method based on markers of arterial health, co-author of the book "Potential Geroprotectors". Machine learning enthusiast, bioinformatician and professional software engineer. Searching for the true cause of aging.
Alexander Fedintsev defines aging as an exponential increase in the probability of
There is no law that says biological species cannot achieve non-senescence. We can gain ten, fifteen, or twenty years of additional healthy life until researchers invent something more to stop aging and set the rate to zero.
Summary
- Aging is defined as the exponential increase in the probability of death from all causes, with the risk of mortality doubling approximately every eight years. - Molecular hallmarks of aging, including stem cell exhaustion and genomic instability, drive the progression of age-related conditions like cancer and heart disease. - Biological immortality in species like the Hydra demonstrates that aging is not an inevitable biological law, suggesting the potential for extreme lifespan extension. - Current interventions like statins and aspirin can postpone the onset of age-related diseases, though they typically delay aging rather than slowing its actual rate. - Monitoring robust biomarkers such as resting pulse rate, glycated hemoglobin, and arterial stiffness is essential for managing health risks and tracking biological aging.
Article
Anti-Aging And Health Risks Management: Hallmarks, Interventions And Biomarkers
At Biohacker Summit 2017 Helsinki, Alexander Fedintsev Framed Aging Not As Fate But As Risk
At Biohacker Summit 2017 Helsinki, held in Helsinki, Finland, on 13 and 14 October 2017, anti-ageing researcher Alexander Fedintsev offered a sobering and provocative account of what it means to grow old. His presentation, *Anti-Aging & Health Risks Management*, did not begin with miracle compounds or Silicon Valley fantasies. It began with mortality.
“Aging,” Fedintsev said, “is actually an increase of probability of death from any cause with advanced age.”
That definition gave the talk its force. Rather than treating aging as a vague decline in vitality, Fedintsev described it as a measurable, exponential rise in danger, one that doubles roughly every eight years. Cancer, heart disease, kidney disease, dementia, even the likelihood of dying from accidents, all climb sharply with time. Aging, in this telling, was not merely about wrinkles or fatigue. It was the steepening curve of vulnerability itself.
The Hallmarks Of Aging Revealed A Body Losing Its Reserves
Fedintsev placed that mortality curve against the now familiar biological “hallmarks of aging,” the cellular and molecular failures that accumulate over the years. Stem cell exhaustion, cellular senescence, mitochondrial dysfunction, protein aggregation, epigenetic drift and genomic instability were presented not as abstract scientific jargon, but as the machinery behind human frailty.
These changes, he argued, helped explain why the diseases of later life arrived not as isolated events, but as a cascade. As DNA damage mounted, cancer risk rose. As cells lost function and tissues hardened, cardiovascular disease followed. As inflammation and metabolic dysfunction spread, the entire organism became more fragile.
The point was not only that aging could be described. It was that aging could be tracked, and perhaps one day managed.
Nature Offered Strange Proof That Aging Was Not Universal
One of the most arresting elements of Fedintsev’s talk came from the animal kingdom, where biology has already produced what humans still struggle to imagine.
He pointed to the naked mole rat, long prized by researchers for its remarkable cancer resistance and unusual lifespan for such a small mammal. He invoked Brandt’s bat, another tiny creature whose longevity made it a startling outlier. He mentioned the Greenland shark, believed to live for centuries, though still subject to slow aging.
And then came the most radical example: hydra.
Fedintsev used the tiny freshwater organism as evidence that senescence is not a universal law. Some species, he said, maintain constant mortality rates regardless of age. They are, in biological terms, non-senescent.
That mattered because it shifted the argument from fantasy to possibility. If nature had already found ways to escape the usual arc of decline, then aging could no longer be dismissed as an unalterable biological commandment.
Lifespan Experiments Suggested Vast Possibilities, But Human Translation Remained Elusive
Fedintsev also revisited one of longevity science’s most tantalising findings: dramatic lifespan extension in simple organisms. In nematodes, he noted, single gene mutations had already produced extraordinary results. In some experiments, worms lived three times longer than normal. In more extreme cases, lifespan had reportedly been extended tenfold.
“We have seen researchers extend the lifespan of organisms ten times over,” Fedintsev said. “If we can eventually translate these results to human beings, it means that a person could possibly live for four thousand years.”
It was an electrifying line, though he delivered it with caution. The distance between worms and humans remained immense. Genetic interventions that worked in laboratory species were not yet practical tools for the public, and even pharmacological approaches in people had delivered much more modest gains.
Still, the implication was impossible to ignore. The biology of aging was plastic. It could be bent. The central scientific question was how far.
Today’s Interventions Delayed Disease More Than They Slowed Aging
If the talk flirted with the extraordinary, it remained grounded in the disappointing reality of present-day medicine. Fedintsev argued that most current interventions did not truly slow the rate of aging. Instead, they shifted the survival curve, postponing the onset of disease rather than altering the underlying tempo of decline.
He cited combinations such as statins and aspirin as examples of treatments that could reduce mortality and add years of healthy life. By his estimate, such approaches might buy roughly a decade. With stronger combinations, healthy diet, physical activity, quality sleep and other supportive habits, perhaps more.
But the distinction he drew was crucial. A therapy that delayed disease was not the same as a therapy that stopped or slowed aging itself. Much of what passed for anti-aging medicine, he suggested, was really risk management.
That was not failure. It was simply honesty.
“Biohacking is about more than just optimization,” Fedintsev said. “Many are aiming towards anti-aging because we do not want to age. We want to optimize our health and cognitive abilities to stop the exponential increase of risk that comes with time.”
Biomarkers Emerged As The Front Line In Managing Biological Age
If true age was biological rather than chronological, then the modern challenge was to measure it. Fedintsev’s answer lay in biomarkers, not gimmicks.
“To effectively manage our health, we must control our biomarkers,” he said. “Robust markers allow us to see the trend of aging and measure the impact of our interventions, ensuring that our lifestyle choices are actually helping us.”
He stressed three qualities of an ideal biomarker: it should correlate with age, predict all-cause mortality and be robust enough to measure meaningfully over time. Some inflammation markers, though scientifically important, fluctuated too sharply to be practical without frequent testing. Better, he argued, were markers that captured long-term trends.
Among those he highlighted was carotid intima media thickness, a measure of arterial wall thickness that can help predict dementia, cognitive impairment and broader cardiovascular risk. He also pointed to glycated hemoglobin as a more stable reflection of long-term metabolic stress and glycation, extending beyond a simple blood glucose snapshot.
The message was plain: if anti-aging remained an aspiration, risk management could still be scientific, disciplined and deeply personal.
The Simplest Warning Sign Might Be The Pulse
For all the sophistication of the biology, Fedintsev reserved some of his strongest emphasis for something almost anyone could monitor at home.
“Resting pulse rate is a simple biomarker that everyone can apply immediately,” he said. “An ideal value is fifty or less. This reflects your overall health and predicts mortality without the need for any cost or invasive procedures.”
The claim carried a democratic power often missing from longevity culture. No elite clinic was needed. No sequencing platform, no infusions, no premium subscription. A pulse, quietly taken at rest, could offer a surprisingly potent signal.
Fedintsev warned that as resting heart rate climbed, mortality risk rose with it. A rate around 60, he suggested, already indicated a slight increase in risk. A resting pulse above 90 was far more ominous, associated with dramatically higher all-cause mortality.
He paired that advice with another practical metric: pulse pressure, the difference between systolic and diastolic blood pressure.
“With advancing age, our arteries become less elastic,” he said. “Monitoring blood pressure and pulse pressure reflects your arterial stiffness, which is a primary cause of many diseases and a key predictor of mortality.”
In the end, the anti-aging message that emerged in Helsinki was less glamorous than the field’s reputation often suggests. It was not a promise of eternal youth. It was a demand for clear-eyed measurement.
The Real Frontier Was Not Immortality, But Time Gained With Precision
What Fedintsev offered at Biohacker Summit 2017 Helsinki was neither a miracle nor a surrender. It was a framework. Aging, he argued, may one day be slowed in a profound way, perhaps even transformed by therapies still beyond the horizon. But until then, the task was to push back against risk with the tools already available: evidence, biomarkers, disciplined intervention and relentless monitoring.
The dream of radical life extension hovered at the edges of the talk, in hydras, bats, sharks and genetically altered worms. But the centre of it was more immediate, and perhaps more urgent. The body was aging now. The curve was already rising. What mattered was how intelligently one responded before it steepened further.
In that sense, *Anti-Aging & Health Risks Management* was not simply a lecture about living longer. It was about learning to read the body before the body delivered its verdict.
Part of Biohacker Summit 2017 Helsinki